IL1B and neoplasm: Like TLR agonists, IL-1β possesses conflicting roles in cancer, where it is frequently associated with tumour progression30,31 but may also mediate anti-tumour responses through cytotoxic T cells32, enhancing effector functions and secondary responses33.